NPF
ECYT

Norris Perne & French’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Norris Perne & French’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,842
Closed -$68K – 177
2014
Q4 		$68K Sell
10,842
-716
-6% -$4.36K 0.01% 162
2014
Q3 		$70K Sell
11,558
-2,558
-18% -$17.5K 0.01% 164
2014
Q2 		$93K Buy
14,116
+300
+2% +$3.38K 0.02% 169
2014
Q1 		$329K Sell
13,816
-2,990
-18% -$43.4K 0.06% 123
2013
Q4 		$179K Sell
16,806
-498
-3% -$5.5K 0.03% 189
2013
Q3 		$230K Sell
17,304
-9,246
-35% -$146K 0.05% 174
2013
Q2 		$348K Buy
+26,550
New +$358K 0.07% 138

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norris Perne & French's ECYT Position: Q1 2015 in Review

Norris Perne & French sold out of Endocyte, Inc. Common Stock (ECYT) in Q1 2015, closing a stake of 10,842 shares — an estimated $68K sold.

Norris Perne & French first reported a position in ECYT in Q2 2013 and held it in 7 quarters. The position peaked at $348K in Q2 2013. 98 funds tracked by Wall St. Rank hold ECYT as of Q1 2015.

  • Norris Perne & French reported no remaining Endocyte, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Norris Perne & French sold 10,842 Endocyte, Inc. Common Stock shares in Q1 2015, an estimated $68K.
  • Norris Perne & French first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 7 quarters.
  • Norris Perne & French's Endocyte, Inc. Common Stock position peaked at $348K in Q2 2013.
  • 98 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q1 2015.

Based on Norris Perne & French's 13F filing for Q1 2015, filed 15 Apr 2015.